Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Seres Therapeutics, Inc. | 8,632 | reported | 15 Feb 2026 | tx 59+2,047,578−182,191 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Feb 2026 | EXERCISE | Seres Therapeutics, Inc. | 231 | — | |
| 15 Feb 2026 | SALE | Seres Therapeutics, Inc. | 75 | 8.47 USD | |
| 15 Feb 2026 | EXERCISE | Seres Therapeutics, Inc. | 98 | 0.00 USD | deriv |
| 15 Feb 2026 | EXERCISE | Seres Therapeutics, Inc. | 133 | 0.00 USD | deriv |
| 15 Nov 2025 | SALE | Seres Therapeutics, Inc. | 1,042 | 17.30 USD | |
| 15 Nov 2025 | EXERCISE | Seres Therapeutics, Inc. | 3,998 | — | |
| 15 Nov 2025 | EXERCISE | Seres Therapeutics, Inc. | 98 | — | |
| 15 Nov 2025 | EXERCISE | Seres Therapeutics, Inc. | 132 | — | |
| 15 Nov 2025 | EXERCISE | Seres Therapeutics, Inc. | 132 | 0.00 USD | deriv |
| 15 Nov 2025 | EXERCISE | Seres Therapeutics, Inc. | 98 | 0.00 USD | deriv |
| 15 Nov 2025 | EXERCISE | Seres Therapeutics, Inc. | 3,998 | 0.00 USD | deriv |
| 26 Sept 2025 | GRANT_AWARD | Seres Therapeutics, Inc. | 3,998 | 0.00 USD | deriv |
| 15 Aug 2025 | EXERCISE | Seres Therapeutics, Inc. | 133 | — | |
| 15 Aug 2025 | EXERCISE | Seres Therapeutics, Inc. | 97 | — | |
| 18 Aug 2025 | SALE | Seres Therapeutics, Inc. | 59 | 16.65 USD | |
| 15 Aug 2025 | EXERCISE | Seres Therapeutics, Inc. | 97 | 0.00 USD | deriv |
| 15 Aug 2025 | EXERCISE | Seres Therapeutics, Inc. | 133 | 0.00 USD | deriv |
| 15 May 2025 | EXERCISE | Seres Therapeutics, Inc. | 133 | — | |
| 15 May 2025 | EXERCISE | Seres Therapeutics, Inc. | 98 | — | |
| 16 May 2025 | SALE | Seres Therapeutics, Inc. | 63 | 7.28 USD | |
| 15 May 2025 | EXERCISE | Seres Therapeutics, Inc. | 133 | 0.00 USD | deriv |
| 15 May 2025 | EXERCISE | Seres Therapeutics, Inc. | 98 | 0.00 USD | deriv |
| 18 Feb 2025 | SALE | Seres Therapeutics, Inc. | 3,338 | 0.81 USD | |
| 15 Feb 2025 | EXERCISE | Seres Therapeutics, Inc. | 2,657 | — | |
| 15 Feb 2025 | EXERCISE | Seres Therapeutics, Inc. | 7,813 | — |